Howard Ullman > Dechert LLP > San Francisco, United States > Lawyer Profile
Dechert LLP Offices
45 Fremont Street
26th Floor
San Francisco, CA 94105
United States
- Firm Profile
- Go to...
Howard Ullman
Work Department
Antitrust/Competition
Position
Counsel
Career
Howard Ullman is counsel in the firm’s antitrust/competition group, focusing his practice on trade regulation, unfair competition, class actions and complex litigation. A seasoned trial lawyer, Mr. Ullman has wide-ranging experience advising on a variety of matters, including Section 1 and Section 2 issues, distribution law and system issues, competitor collaborations, joint ventures, pricing issues, non-price restraints and dealer termination issues.
Mr. Ullman regularly advises on matters at the intersection of antitrust and intellectual property, as well as matters involving the Robinson-Patman Act, the California Unfair Practices Act and Cal. Bus. and Prof. Code Section 17200. His clients include top healthcare, technology, financial services and retail companies.
Some of Mr. Ullman’s key matters include acting for Delta Dental of California and other Delta Dental entities in multi-district litigation, Nanya Technology Corporation and Nanya Technology Corporation USA in one of the largest national DRAM antitrust price-fixing cases and Microsoft on a variety of intellectual property related antitrust matters. His other clients have included PG&E Corporation, Equifax, Dow AgroSciences, Boiron, Fujifilm, Fortress Investment Group and One Technologies, among others.
Education
- University of Chicago, B.A., 1989
- Harvard Law School, J.D., 1992
Lawyer Rankings
United States > Antitrust > Civil litigation/class actions: defense
Dechert LLP offers global and nationwide antitrust capabilities to its growing client base which features names such as Endo Pharmaceuticals and Marriott International. The firm is well-versed with a range of litigation including conspiracies related to advertising, bid rigging and price fixing as well as antitrust patent litigation and rule of reason standards. Based in Philadelphia is co-head Steven Bizar, who focuses his practice on trial work, particularly antitrust and trade regulation and is well-regarded for his success in defending against section 1 and 2 Sherman Act cases and class action lawsuits. Also co-heading the team from Washington DC is Mike Cowie, a healthcare and life sciences law expert who focuses on government merger investigations and litigation. Also in Philadelphia are George G Gordon who has significant experience in representing companies in class actions and investigations concerning patent enforcement, pricing concerns and marketing, and Julia Chapman, who is well-versed in all stages of litigation particularly in the life sciences, specialty chemicals and tech fields. Experienced trial lawyer Shari Ross Lahlou, based in DC, acts for Fortune 500 clients including Johnson & Johnson. The group has expanded its team and strengthened its high-tech antitrust expertise with the hires from Orrick, Herrington & Sutcliffe LLP in January 2023 including Jay Jurata in DC, former head of Orrick’s antitrust and competition group, Russell Cohen and Howard Ullman in the San Francisco office.
Lawyer Rankings
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation